CIK 0001157601
- Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 267-824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 4 Open-market sale Director sold 188,322 shares at $0.55 ($103,050)
- 4 Open-market sale Director sold 5,436,673 shares at an average $0.55 ($3,009,262)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Other disposition Director disposed of 4,120,854 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 6,818 shares (grant or award)
- 4 Grant or award Director acquired 6,817 shares (grant or award)
- 4 Grant or award Director acquired 7,953 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 49,998 shares (grant or award)
- 4 Grant or award Director acquired 31,817 shares (grant or award)
- 4 Grant or award President and CEO acquired 150,000 shares (grant or award)
- 4 Open-market buy Director bought 6,857,143 shares at $1.75 ($12,000,000)
- 4 Open-market buy Director bought 350,000 shares at $1.75 ($612,500)
- 4 Open-market buy Director bought 50,000 shares at $1.75 ($87,500)
Page 16 of 29 · 564 filings